Atopic dermatitis (AD) is a chronic inflammatory skin disease.
Multiple signaling pathways may combine to produce pathological changes in AD.
Quercetin is a potent pleiotropic molecule that regulates multiple pathways.
Quercetin bioavailability limits its usage in clinical settings.
Various approaches to improve quercetin pharmacokinetics are addressed.